D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
PUT
Vroom Inc
VRM
$36.9M
| $390K | ﹤0.01% |
+125
| New | +$405K |
|
3477
Portland General Electric
POR
$6.02B
| $388K | ﹤0.01% |
8,165
-49,468
| -86% | -$2.16M |
|
3478
Ebang International Holdings
EBON
| $387K | ﹤0.01% |
1,624
-3,376
| -68% | -$723K |
|
3479
Supernus Pharmaceuticals
SUPN
$2.68B
| $387K | ﹤0.01% |
14,764
-6,643
| -31% | -$186K |
|
|
HPP
3480
Hudson Pacific Properties
HPP
$834M
| $385K | ﹤0.01% |
2,027
-29,862
| -94% | -$5.33M |
|
3481
Hain Celestial
HAIN
$47.8M
| $384K | ﹤0.01% |
8,815
-43,037
| -83% | -$1.83M |
|
|
EPZM
3482
DELISTED
Epizyme, Inc
EPZM
| $384K | ﹤0.01% |
44,130
-51,608
| -54% | -$534K |
|
3483
CALL
Methanex
MEOH
$4.32B
| $379K | ﹤0.01% |
+10,300
| New | +$403K |
|
3484
BGC Group
BGC
$5.58B
| $378K | ﹤0.01% |
78,219
-818,631
| -91% | -$3.48M |
|
3485
Capital Southwest
CSWC
$1.46B
| $378K | ﹤0.01% |
17,063
-68,798
| -80% | -$1.4M |
|
|
PGRE
3486
DELISTED
Paramount Group
PGRE
| $378K | ﹤0.01% |
+37,304
| New | +$350K |
|
3487
Hyster-Yale Materials Handling
HY
$593M
| $377K | ﹤0.01% |
+4,331
| New | +$379K |
|
|
RAAS
3488
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
| $377K | ﹤0.01% |
+9,150
| New | +$602K |
|
3489
Applied Industrial Technologies
AIT
$12.8B
| $375K | ﹤0.01% |
4,117
-2,593
| -39% | -$220K |
|
3490
Old Republic International
ORI
$10.3B
| $375K | ﹤0.01% |
17,150
-91,907
| -84% | -$1.84M |
|
3491
Western Alliance Bancorporation
WAL
$9.07B
| $375K | ﹤0.01% |
+3,972
| New | +$329K |
|
3492
Dillards
DDS
$8.87B
| $374K | ﹤0.01% |
3,874
+231
| +6% | +$18.8K |
|
3493
CALL
Kinross Gold
KGC
$28.5B
| $374K | ﹤0.01% |
+56,100
| New | +$390K |
|
3494
CALL
EQT Corp
EQT
$33.2B
| $372K | ﹤0.01% |
20,000
| – | – |
|
|
SLAMU
3495
DELISTED
Slam Corp. Unit
SLAMU
| $372K | ﹤0.01% |
+37,546
| New | +$378K |
|
3496
PUT
PagerDuty
PD
$700M
| $370K | ﹤0.01% |
+9,200
| New | +$420K |
|
3497
Omega Flex
OFLX
$298M
| $366K | ﹤0.01% |
2,319
-100
| -4% | -$15.7K |
|
3498
Power Integrations
POWI
$3.54B
| $365K | ﹤0.01% |
4,481
-3,626
| -45% | -$316K |
|
3499
Ionis Pharmaceuticals
IONS
$9.35B
| $364K | ﹤0.01% |
8,106
-5,311
| -40% | -$296K |
|
|
PRO
3500
DELISTED
PROS Holdings
PRO
| $363K | ﹤0.01% |
8,540
-14,524
| -63% | -$662K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.